chr20-10262538-G-A

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_130811.4(SNAP25):c.-63-12891G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.362 (AC=54,961) in the gnomAD database across 151,862 control chromosomes, including 10,738 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.427. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 10738 hom., cov: 32)

Consequence

SNAP25
NM_130811.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.138

Publications

5 publications found
Variant links:
Genes affected
SNAP25 (HGNC:11132): (synaptosome associated protein 25) Synaptic vesicle membrane docking and fusion is mediated by SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) located on the vesicle membrane (v-SNAREs) and the target membrane (t-SNAREs). The assembled v-SNARE/t-SNARE complex consists of a bundle of four helices, one of which is supplied by v-SNARE and the other three by t-SNARE. For t-SNAREs on the plasma membrane, the protein syntaxin supplies one helix and the protein encoded by this gene contributes the other two. Therefore, this gene product is a presynaptic plasma membrane protein involved in the regulation of neurotransmitter release. Two alternative transcript variants encoding different protein isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
SNAP25 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 18
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
SNAP25-AS1 (HGNC:44312): (SNAP25 antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_130811.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.4269 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_130811.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNAP25
NM_130811.4
MANE Select
c.-63-12891G>A
intron
N/ANP_570824.1P60880-1
SNAP25
NM_001322902.2
c.-63-12891G>A
intron
N/ANP_001309831.1P60880-2
SNAP25
NM_001322903.2
c.-63-12891G>A
intron
N/ANP_001309832.1P60880-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNAP25
ENST00000254976.7
TSL:1 MANE Select
c.-63-12891G>A
intron
N/AENSP00000254976.3P60880-1
SNAP25
ENST00000304886.6
TSL:1
c.-63-12891G>A
intron
N/AENSP00000307341.2P60880-2
SNAP25
ENST00000961779.1
c.-63-12891G>A
intron
N/AENSP00000631838.1

Frequencies

GnomAD3 genomes
AF:
0.362
AC:
54938
AN:
151748
Hom.:
10740
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.253
Gnomad AMI
AF:
0.360
Gnomad AMR
AF:
0.405
Gnomad ASJ
AF:
0.546
Gnomad EAS
AF:
0.0904
Gnomad SAS
AF:
0.285
Gnomad FIN
AF:
0.374
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.431
Gnomad OTH
AF:
0.406
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.362
AC:
54961
AN:
151862
Hom.:
10738
Cov.:
32
AF XY:
0.359
AC XY:
26662
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.253
AC:
10504
AN:
41446
American (AMR)
AF:
0.404
AC:
6152
AN:
15214
Ashkenazi Jewish (ASJ)
AF:
0.546
AC:
1896
AN:
3470
East Asian (EAS)
AF:
0.0906
AC:
465
AN:
5132
South Asian (SAS)
AF:
0.287
AC:
1376
AN:
4802
European-Finnish (FIN)
AF:
0.374
AC:
3942
AN:
10532
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.431
AC:
29293
AN:
67954
Other (OTH)
AF:
0.402
AC:
848
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1758
3516
5273
7031
8789
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
528
1056
1584
2112
2640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.416
Hom.:
22732
Bravo
AF:
0.359

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.138
AC:
16883
AN:
122552
Turkish Variome
AF:
0.457
AC:
707
AN:
1546
Hom.:
170
ABraOM SABE-WGS-1171
AF:
0.423
AC:
988
AN:
2334
Hom.:
228

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.8
DANN
Benign
0.75
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.